结直肠癌
药物基因组学
生物信息学
生物
基因
类有机物
癌症研究
癌症
生物信息学
计算生物学
代谢组学
PTEN公司
癌细胞
细胞
基因签名
抗药性
医学
生物标志物
清脆的
基因表达谱
基因表达调控
溶质载体族
微阵列分析技术
基因组学
癌症干细胞
基因表达
转移
作者
Marco Strecker,Keren Zohar,Martin Böttcher,Thomas Wartmann,Henry Freudenstein,Maximilian Doelling,Mihailo Andric,Wenjie Shi,Or Kakhlon,Katrin Hippe,Beatrix Jahnke,Dimitrios Mougiakakos,Franziska Baenke,Daniel E. Stange,Roland S. Croner,Michal Linial,Ulf D. Kahlert
标识
DOI:10.1002/1878-0261.70129
摘要
Colorectal cancer (CRC) represents the third leading cause of cancer-related deaths. Integrating cellular and molecular data from individual patients has become valuable for diagnosis, prognosis, and treatment selection. Here, we present a comparative mRNA-seq analysis of tissue samples from 32 CRC patients, pairing tumors with adjacent healthy tissues. Differential expression gene (DEG) analysis revealed dysregulated metabolic programs. We focused on the impact of overexpressed SLC7A11 (xCT) and SLC3A2, which compose the cystine/glutamate transporter (Xc-) system. To assess the oncogenic potential of the Xc- system, we analyzed gene perturbations from CRISPR screens across various cell types and used functional assays in five primary patient-derived organoid models. We identified a previously uncharacterized cell surface protein signature predicting chemotherapy resistance and highlighted the causality and potential of pharmacological blockage of ferroptosis as a promising avenue for cancer therapy. Redox homeostasis, ion/amino acid transporters, and regulators of neuronal survival and differentiation were pathways associated with these co-dependent genes in patient specimens. This study highlights several potential clinical targets for CRC therapy and promotes the use of patient-derived organoids oids to functionally validate in silico predictions.
科研通智能强力驱动
Strongly Powered by AbleSci AI